Responding to the Supreme Court hearing oral argument on the case Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (AHM v. FDA), Amnesty International USA’s National Director of Programs, Tarah Demant, said:
“The U.S. Supreme Court is hearing a case that could, again, drastically harm the lives of women, girls, and people who can get pregnant across the country by even further restricting access to abortion nationwide.
“This case is clearly politically motivated, and it is instigated and funded by anti-abortion actors who seek to end abortion in all cases and to strip people of the right to make decisions over their own bodies. Mifepristone is safe, effective, and has been used by more than five million people in the United States for abortion and miscarriage care since the FDA approved it more than 20 years ago.
“All people have the human right to the highest attainable standard of health, including access to the medication they need, without unnecessary interference from the judiciary or politicians.”
Mifepristone is one of two medicines most commonly used in medication abortion in the United States. Medication abortion accounted for 63 percent of abortions in the healthcare system in the United States in 2023, up from 53 percent in 2020.
More information
Access to abortion is a human right. Laws and policies that affect the lives of people who can become pregnant must ensure access to abortion and full bodily autonomy. Laws restricting access to safe abortion violate the human rights of women and people who can get pregnant. Those who are already marginalized are disproportionately affected by such laws. They include people on low income; refugees and migrants; adolescents; lesbian and bisexual women and girls; transgender and gender non-conforming individuals; minority or Indigenous women. Read more.
Take action to protect the right to abortion.
Contact: [email protected]